FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 60 filers reported holding FOGHORN THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $89,184 | -15.8% | 15,869 | +0.5% | 0.00% | – |
| Q1 2024 | $105,958 | +17.1% | 15,791 | +16.2% | 0.00% | – |
| Q4 2023 | $90,496 | +28.0% | 13,588 | +0.1% | 0.00% | – |
| Q3 2023 | $70,710 | -28.4% | 13,572 | 0.0% | 0.00% | – |
| Q2 2023 | $98,804 | +18.6% | 13,572 | 0.0% | 0.00% | – |
| Q1 2023 | $83,332 | -1.1% | 13,572 | 0.0% | 0.00% | – |
| Q4 2022 | $84,280 | -8.4% | 13,572 | +28.0% | 0.00% | – |
| Q3 2022 | $92,000 | -37.8% | 10,600 | 0.0% | 0.00% | – |
| Q2 2022 | $148,000 | -9.2% | 10,600 | 0.0% | 0.00% | – |
| Q1 2022 | $163,000 | -39.0% | 10,600 | -9.7% | 0.00% | – |
| Q4 2021 | $267,000 | -6.0% | 11,736 | -43.6% | 0.00% | – |
| Q3 2021 | $284,000 | +29.7% | 20,792 | 0.0% | 0.00% | – |
| Q2 2021 | $219,000 | -12.7% | 20,792 | +10.9% | 0.00% | – |
| Q1 2021 | $251,000 | -34.8% | 18,742 | -0.8% | 0.00% | -100.0% |
| Q4 2020 | $385,000 | – | 18,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,674,120 | $89,225,805 | 3.98% |
| Euclidean Capital LLC | 1,573,761 | $11,079,277 | 2.85% |
| Birchview Capital, LP | 264,843 | $1,864,495 | 1.40% |
| Artal Group S.A. | 1,720,720 | $12,114 | 0.38% |
| Rockwood Wealth Management, LLC | 214,677 | $1,511,327 | 0.26% |
| Alphabet Inc. | 500,901 | $3,526,343 | 0.19% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 777,525 | $5,473,776 | 0.12% |
| CORNERCAP INVESTMENT COUNSEL INC | 26,163 | $184,188 | 0.03% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 343,720 | $2,419,789 | 0.03% |
| WADE G W & INC | 107,770 | $759 | 0.03% |